Therefore, syngeneic Balb/c mice with intact immune systems were subsequently utilized to determine whether BHS can chemosensitise breast cancer in immunocompetent mice by inhibiting the EV‐Apo/TAM/PD‐L1 pathway. This evidence concerns the gene CD274 and breast carcinoma.